Published on
March 19, 2026
- 16:29 GMT
Lunai Bioworks Engages Initial U.S. Countermeasure Opportunities Following $400M–$1.2B Consortium Launch
AI Platform Begins Government and Institutional Discussions to Accelerate Chemical Threat Countermeasure Development Lunai Bioworks Inc. (NASDAQ:LNAI) SACRAMENTO, CA, UNITED STATES, March 19, 2026 /EINPresswire.com/ -- Lunai Bioworks (NASDAQ: LNAI), …
Distribution channels:
Healthcare & Pharmaceuticals Industry, Military Industry
...
